Life sciences leaders cite similar distress drivers and expect IRA-linked pricing pressure; global pricing dynamics, competitive intensity, and payer/PBM leverage threaten pricing power while AI ROI ...
Meena Bansal, MD, discusses the evolving MASH pipeline and why precision phenotyping, biomarkers, and cardiovascular outcomes ...
Fragmented subspecialty care and underbuilt survivorship pathways risk overwhelming primary care as the survivor population ...
Pathogenic variants were present in 0.5% (GMC) to 0.9% (UKBB), with MITF E318K accounting for most carriers and reaching 0.8% in UKBB. Enrichment exceeded a 2.5% testing threshold in high-risk ...
Full results from the pivotal B-Well 1 and B-Well 2 phase 3 trials confirm that bepirovirsen delivers statistically significant functional cure rates in chronic hepatitis B. Bepirovirsen (GSK/Ionis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results